![The Community begins today to administer the fourth dose against COVID-19 to users and workers of residences in the region | Madrid's community The Community begins today to administer the fourth dose against COVID-19 to users and workers of residences in the region | Madrid's community](https://www.comunidad.madrid/sites/default/files/escudero_y_dancausa_vacunas_covid19_-_2.jpeg)
The Community begins today to administer the fourth dose against COVID-19 to users and workers of residences in the region | Madrid's community
![La Moncloa. 11/11/2022. More than 60% of people aged over 80 years have a second booster dose of COVID-19 [Government/News] La Moncloa. 11/11/2022. More than 60% of people aged over 80 years have a second booster dose of COVID-19 [Government/News]](https://www.lamoncloa.gob.es/serviciosdeprensa/notasprensa/sanidad14/PublishingImages/Recursos/150321vacunas3.jpg)
La Moncloa. 11/11/2022. More than 60% of people aged over 80 years have a second booster dose of COVID-19 [Government/News]
Stick with it for Annual Flu and COVID-19 Booster Vax at Naval Hospital Bremerton > Navy Medicine > News
![Fifth Covid jab for over 60s and vulnerable recommended by Ministry of Health in Spain | Sur in English Fifth Covid jab for over 60s and vulnerable recommended by Ministry of Health in Spain | Sur in English](https://s2.ppllstatics.com/surinenglish/www/multimedia/2023/08/28/covid-flu-vaccination.jpg)
Fifth Covid jab for over 60s and vulnerable recommended by Ministry of Health in Spain | Sur in English
![Distribution of SPIKEVAX Bivalent (elasomeran/imelasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels - Canada.ca Distribution of SPIKEVAX Bivalent (elasomeran/imelasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels - Canada.ca](https://recalls-rappels.canada.ca/sites/default/files/inline-images/Spikevax%200%20%28Zero%29%20o%20%28Omicron%29%20carton%20label.png)
Distribution of SPIKEVAX Bivalent (elasomeran/imelasomeran) COVID-19 Vaccine with English-only Vial and Carton Labels - Canada.ca
![Covid-19: Spain to offer Pfizer or Moderna booster shot to recipients of single-dose Janssen vaccine | Society | EL PAÍS English Covid-19: Spain to offer Pfizer or Moderna booster shot to recipients of single-dose Janssen vaccine | Society | EL PAÍS English](https://images.english.elpais.com/resizer/GhkO0jmjbKdHhPXwmXhvZt4ty6U=/414x0/filters:focal(3190x2030:3200x2040)/cloudfront-eu-central-1.images.arcpublishing.com/prisa/7WC3IK5QEB5GRVSQ5AHLR5SSKQ.jpg)
Covid-19: Spain to offer Pfizer or Moderna booster shot to recipients of single-dose Janssen vaccine | Society | EL PAÍS English
Overview of the implementation of COVID-19 vaccination strategies and vaccine deployment plans in the EU/EEA 8 September 2022
![Revista de Pediatría de Atención Primaria - Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations Revista de Pediatría de Atención Primaria - Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations](https://pap.es/files/1117-1746-fichero/table1.jpg)
Revista de Pediatría de Atención Primaria - Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations
![RBDCOV initiates the first Phase III clinical trial of HIPRA's Covid-19 vaccine in immunocompromised people - EN - IDIBGI RBDCOV initiates the first Phase III clinical trial of HIPRA's Covid-19 vaccine in immunocompromised people - EN - IDIBGI](https://idibgi.org/en/wp-content/uploads/sites/6/2022/05/Clinical-Trial-I.jpg)
RBDCOV initiates the first Phase III clinical trial of HIPRA's Covid-19 vaccine in immunocompromised people - EN - IDIBGI
![Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study - eClinicalMedicine Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/f319102b-6a4a-4d84-bef1-7cb2e4b7a481/gr1.jpg)
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study - eClinicalMedicine
![La Moncloa. 30/03/2023. Miñones: The HIPRA vaccine is an unprecedented scientific and health milestone that shows Spain's commitment to improving people's health [Government/News] La Moncloa. 30/03/2023. Miñones: The HIPRA vaccine is an unprecedented scientific and health milestone that shows Spain's commitment to improving people's health [Government/News]](https://www.lamoncloa.gob.es/serviciosdeprensa/notasprensa/sanidad14/PublishingImages/Ministro/300323-minones.jpg)